464 related articles for article (PubMed ID: 34718336)
1. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
3. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
[TBL] [Abstract][Full Text] [Related]
4. Exosomal miR-3180-3p inhibits proliferation and metastasis of non-small cell lung cancer by downregulating FOXP4.
Chen T; Liu Y; Chen J; Zheng H; Chen Q; Zhao J
Thorac Cancer; 2021 Feb; 12(3):372-381. PubMed ID: 33350095
[TBL] [Abstract][Full Text] [Related]
5. MiR-323-3p Targeting Transmembrane Protein with EGF-Like and 2 Follistatin Domain (TMEFF2) Inhibits Human Lung Cancer A549 Cell Apoptosis by Regulation of AKT and ERK Signaling Pathways.
Fan JM; Zheng ZR; Zeng YM; Chen XY
Med Sci Monit; 2020 Feb; 26():e919454. PubMed ID: 32009129
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y
Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022
[TBL] [Abstract][Full Text] [Related]
7. MiroRNA-31-3p Promotes the Invasion and Metastasis of Non-Small-Cell Lung Cancer Cells by Targeting Forkhead Box 1 (FOXO1).
Zeng X; Liu D; Peng G; Liu J; Yang H
Comput Math Methods Med; 2022; 2022():4597087. PubMed ID: 35126623
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
10. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p.
Wei F; Ma C; Zhou T; Dong X; Luo Q; Geng L; Ding L; Zhang Y; Zhang L; Li N; Li Y; Liu Y
Mol Cancer; 2017 Jul; 16(1):132. PubMed ID: 28743280
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN.
Ren P; Gong F; Zhang Y; Jiang J; Zhang H
Tumour Biol; 2016 Mar; 37(3):3215-25. PubMed ID: 26432332
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
13. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9.
Chen J; Ding C; Yang X; Zhao J
J BUON; 2021; 26(5):1832-1841. PubMed ID: 34761590
[TBL] [Abstract][Full Text] [Related]
14. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
Wang A; Wang J
DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
[TBL] [Abstract][Full Text] [Related]
15. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
Shao N; Song L; Sun X
Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
[TBL] [Abstract][Full Text] [Related]
16. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p.
Chen QF; Kong JL; Zou SC; Gao H; Wang F; Qin SM; Wang W
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7408-7418. PubMed ID: 31539128
[TBL] [Abstract][Full Text] [Related]
18. The regulation of Neuropilin 1 expression by miR-338-3p promotes non-small cell lung cancer via changes in EGFR signaling.
Ding Z; Zhu J; Zeng Y; Du W; Zhang Y; Tang H; Zheng Y; Qin H; Liu Z; Huang JA
Mol Carcinog; 2019 Jun; 58(6):1019-1032. PubMed ID: 30811684
[TBL] [Abstract][Full Text] [Related]
19. MiR-34c-3p suppresses the proliferation and invasion of non-small cell lung cancer (NSCLC) by inhibiting PAC1/MAPK pathway.
Zhou YL; Xu YJ; Qiao CW
Int J Clin Exp Pathol; 2015; 8(6):6312-22. PubMed ID: 26261507
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
Zhao L; Bi M; Zhang H; Shi M
Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
[No Abstract] [Full Text] [Related]
[Next] [New Search]